{"id":558716,"date":"2026-06-12T02:00:00","date_gmt":"2026-06-12T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita\/"},"modified":"2026-06-17T11:00:07","modified_gmt":"2026-06-17T09:00:07","slug":"approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita\/","title":{"rendered":"Approcci terapeutici all\u2019avanguardia per la PBC, la PSC e l\u2019AIH: quali sono le novit\u00e0?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Gli agonisti del PPAR come terapia di seconda linea si sono dimostrati efficaci nella colangite biliare primitiva (PBC) non solo negli studi clinici, ma anche in contesti reali, come dimostrano i recenti risultati della ricerca. Nella colangite sclerosante primitiva (PSC), l\u2019acido norucholico (NCA) ha migliorato i parametri di laboratorio rilevanti e ha dimostrato effetti epatoprotettivi. Per quanto riguarda l\u2019epatite autoimmune (AIH), in una recente analisi \u00e8 stata valutata l\u2019efficacia del micofenolato mofetile rispetto all\u2019azatioprina, entrambi in combinazione con il prednisolone.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fapprocci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Gli agonisti del PPAR come terapia di seconda linea si sono dimostrati efficaci nella colangite biliare primitiva (PBC) non solo negli studi clinici, ma anche in contesti reali, come dimostrano&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fapprocci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Malattie epatiche autoimmuni  ","footnotes":"[{\"content\":\"<em>Criteri di risposta POISE = ALP [fosfatasi alcalina] <1,67\\u00d7 ULN, nonch\\u00e9 una riduzione del 15% dell\\u2019ALP e bilirubina totale entro i valori normali dopo 1 anno.  <\\\/em>\",\"id\":\"4b3154c2-2e71-44d9-b2fc-5c3e68c86fac\"},{\"content\":\"<em>ULN (upper limit of normal) = limite superiore dell'intervallo di normalit\\u00e0<\\\/em>\",\"id\":\"85539fe2-6d0e-4c82-9a2e-85cb9bf78fe2\"}]"},"category":[11550,11401,11306,11522,11515],"tags":[94716,94715,72867,14351,32564,32568,63841,72870,94718,94717,32566,27678,32569,11951],"powerkit_post_featured":[],"class_list":["post-558716","post","type-post","status-publish","format-standard","category-rx-it","category-gastroenterologia-ed-epatologia","category-medicina-interna-generale","category-rapporti-del-congresso","category-studi","tag-acido-norucholico","tag-agonisti-dei-ppar","tag-aih-it","tag-azatioprina","tag-colangite-biliare-primaria","tag-colangite-sclerosante-primaria","tag-epatite-autoimmune","tag-malattie-epatiche-autoimmuni","tag-micofenolato-mofetile-2","tag-nca","tag-pbc-it","tag-prednisolone-it","tag-psc-it","tag-terapia-di-seconda-linea","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-28 00:14:24","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":558740,"slug":"abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades","post_title":"Abordagens terap\u00eauticas inovadoras para a PBC, a PSC e a AIH: Quais s\u00e3o as novidades?","href":"https:\/\/medizinonline.com\/pt-pt\/abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades\/"},"es_ES":{"locale":"es_ES","id":558746,"slug":"enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay","post_title":"Enfoques terap\u00e9uticos innovadores para la CBP, la CSP y la HAI: \u00bfqu\u00e9 novedades hay?","href":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/558716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=558716"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/558716\/revisions"}],"predecessor-version":[{"id":558720,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/558716\/revisions\/558720"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=558716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=558716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=558716"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=558716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}